http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0967997-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0024795f45a646ef64b3664ab8a26d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 1998-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7c6f26adaad89b41138ef061696fda8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26e2ecc3d53531baa2b9a25117d3c096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae07ed00d36024467f68d5fa6ad4ab05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d3e42bb02f4d4d4fb4b0b1fdd44e58a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fd655beec0145599e4774de867f2b52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf7292a895e9d601309518bbbf7e757d
publicationDate 2003-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0967997-B1
titleOfInvention Pharmaceutical composition for eliminating membrane-mediated cell resistance
abstract The invention relates to a pharmaceutical composition containing an inhibitor for diaphragm pumps and a photoaffinity-marked chemotherapeutic agent. Said composition is suitable for eliminating membrane-mediated cell resistance, especially membrane-mediated multi-chemoresistance of tumor cells.
priorityDate 1997-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12040205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128898221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136126664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87057664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136275269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57294487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136314073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57317596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395653

Total number of triples: 52.